LALACA 75

LALACA 75 လာလာကာ

Ingredient ပါဝင်ပစ္စည်းများ
  • Pregabalin 75 mg ပရီဂါဘာလင် ၇၅ မီလီဂရမ်

Composition and Indication Composition and Indication
  • Pregabalin 75 mg for Neuropathic Pain Pregabalin 75 mg (Neuropathic Pain Reliever)

Country of Origin: Korea

Manufactured by: Yoo Young Pharmaceutical

Imported and Distributed by: Tri Care Co., Ltd

LALACA 75 can be used for

Diabetic Peripheral Neuropathy

Post-herpetic Neuralgia

Low Back Pain with Radiculopathy

Other Neuropathic Pain

Spinal Cord Injury

Fibromyalgia

Epilepsy or Seizure

Generalize Anxiety Disorder

Post-operative Pain

ဆီးချိုကြောင့် အာရုံကြောများထိခိုက်ပျက်စီးသောရောဂါ

ရေယုန်ပေါက်ပြီးနောက် အာရုံကြော နာကျင်ခြင်း

အာရုံကြောညှပ်ခြင်းကြောင့် ခါးနာခြင်း

အခြားအာရုံကြောထိခိုက်မှုများကြောင့် နာကျင်ခြင်း

ကျောရိုးမကြီး ထိခိုက်မိခြင်း

ကြွက်သားထုံ၍ နာကျင်ကိုက်ခဲခြင်း

အတက်ရောဂါများ

စိုးရိမ်သောကများသောရောဂါ

ခွဲစိတ်ပြီးလူနာများတွင် အနာသက်သာစေရန်အတွက်လည်း အသုံးပြုကြပါသည်။

10 X 10 Capsules 10 X 10 Capsules

Adult Dosage

Management of neuropathic pain associated with diabetic peripheral neuropathy:

§  Recommended maximum therapeutic dosage is 300 mg/d

§  Suggested starting dosage is 50 mg 3 times daily

§  Dosage can increase to 300 mg/d within 1 week of starting treatment.

Management of neuropathic pain associated with spinal cord injury

§  Recommended therapeutic dosage is 150 mg to 600 mg daily

§  Recommended starting dosage is 75 mg twice daily

§  Dosage may be increased to 150 mg twice daily within 1 week of initiating treatment

§  Patients with suboptimal pain relief following 2 to 3 weeks of treatment with 150 mg twice daily may be increased up to 300 mg twice daily

§  In spinal cord injury, pain improvement can be seen as early as 1 week after initiating treatment

§  However, to evaluate the efficacy of pregabalin, it is recommended that the medication be tried for 4 to 6 weeks if the patient tolerates it.

Management of postherpetic neuralgia

§  Recommended therapeutic dosage is 150 mg to 300 mg daily, divided into dosing twice or thrice daily

§  Recommended starting dosage is 75 mg twice daily or 50 mg thrice daily

§  Dosage can be increased to 300 mg daily within 1 week of starting treatment

§  After 2 to 4 weeks of treatment with 300 mg daily, patients with suboptimal pain relief can be increased to 600 mg, divided into twice daily or thrice daily.

Management of fibromyalgia

§  Recommended therapeutic dosage is 300 mg to 450 mg daily

§  Recommended initial dosage is 150 mg/d, divided into twice-daily doses

§  Dosage can be increased to 300 mg daily within 1 week of starting treatment

§  Patients with suboptimal pain relief on 300 mg daily may further increase to 450 mg daily, divided into twice-daily dosing.

Adjunctive therapy for adults with partial onset seizures

Pregabalin is FDA-approved only as an adjunctive for treating partial-onset seizures

§  Effective dosage is 150 mg to 600 mg daily, divided twice or thrice-daily dosing

§  Suggested starting dosage is no greater than 150 mg daily, and the total dosage can increase to 600 mg daily. 

Generalized anxiety disorder

§  Initial dosage is 75 mg daily, which may increase by 75 mg during the first week of treatment maximum dosage can be up to 300 mg thrice daily.

Social anxiety disorder

§  Initial dosage is 100 mg thrice daily, which may increase by 150 mg daily over 1 week

§  Dosage may increase to 600 mg daily based on response and tolerability. 

Dosage MM